Greg Swan

Greg Swan is a seasoned professional in the fields of business development and life sciences, currently serving as a Business Development Manager at Meridian Bioscience Inc. since July 2025. Previously, Greg held roles at Avantor, where responsibilities included supporting customer needs in cell and gene therapy, as well as integrating new product initiatives into cohesive offerings. Prior experience includes positions as a Senior Account Manager at Abcam, an Inside Sales Specialist at Tecan, and a Floor Manager at Williams-Sonoma, Inc. Greg's academic background features a Master's degree in Immunology from Duke University, during which projects focused on T-cell differentiation, and a Bachelor of Science with Honors in Biology and Medical Humanities from Davidson College. Additionally, Greg has contributed to cancer research as a fellow at the National Cancer Institute and served on the Human Subject Institutional Review Board at Davidson College.